lactobacilli has been proposed as an alternative treatment against infections by E. coli (Stapleton et al. 2011) . Probiotics are defined as "live microorganisms which, when administered in adequate amounts, exert a beneficial physiological effect in the host health" (FAO/WHO 2001; Hill et al. 2014) . Stapleton et al. (2011) reported the association of a reduction in recurrent urinary tract infection by the use of Lactin-V (Lactobacillus crispatus intravaginal suppository probiotic) after the standard treatment for cystitis.
Probiotics can exert beneficial effects by different mechanisms, such as production of antimicrobial substances (organic acids, hydrogen peroxide and bacteriocins) (Nader-Macías et al. 2008; Martín and Suárez 2010; Mirmonsef et al. 2012; Stoyancheva et al. 2014 ) and biosurfactants (Gudiña et al. 2010) , modulation of immune system (Oelschlaeger 2010; Joo et al. 2011; De Gregorio et al. 2016 ) and biofilm formation (Martín et al. 2008; Leccese Terraf et al. 2012) . Colonization capability, including adhesion to epithelial cells or mucosal surfaces that contribute to the beneficial effect through the time, is also one of the mechanisms suggested for probiotics (Nader-Macías et al. 2008; Bouchard et al. 2015) . The aims of this work were: to evaluate the susceptibility of E. coli to antagonistic substances produced by lactobacilli, to determine the Lactobacillus reuteri CRL 1324 ability of adhesion to and internalization into human cervical HeLa cells, and to assess the L. reuteri CRL 1324 capability to counteract UPEC adhesion to and internalization into human cervical HeLa cells.
Materials and methods

Bacterial strains and culture conditions
Three vaginal Lactobacillus strains and two E. coli strains were used (Table 1) . The three Lactobacillus strains were previously selected for their in vitro beneficial characteristics, such as production of hydrogen peroxide, inhibition of urogenital pathogens, auto-aggregation, adhesion to mucin and ability to form biofilm in culture media without Tween 80 (Juárez Tomás et al. 2005; Juárez Tomás et al. 2011; Leccese Terraf et al. 2012; Leccese Terraf et al. 2014) . Lactobacilli were stored in yeast extract milk at −20 °C and sub-cultured twice in De Man-Rogosa-Sharpe (MRS) broth (De Man et al. 1960) , for 12 h at 37 °C, under static conditions. A third sub-culture was performed in MRS and MRS without Tween 80 (MRS-T) and incubated for 12 h at 37 °C (Leccese Terraf et al. 2012) . MRS-T was used because this medium favored biofilm formation and allowed the growth of most of the Lactobacillus strains evaluated (Leccese Terraf et al. 2012) .
Escherichia coli strains were isolated from human urine samples in Tucumán, Argentina, and identified by standard phenotypic techniques (Table 1) . These microorganisms were stored at −20 °C in BHI (Brain Heart Infusion, composition in g/l: 200 infusion brain, 250 heart infusion, 10 peptone, 5NaCl, 2 glucose and 2.50 Na 2 HPO 4 ) added with 20% glycerol. Before the experiments, each E. coli strain was sub-cultured in BHI broth for 12 h at 37 °C, under aerobic conditions without agitation. A second sub-culture was performed in BHI or LAPTg broth (Raibaud et al. 1973) prior to use.
Susceptibility of E. coli to antagonistic substances produced by vaginal lactobacilli
The antagonistic effect of the culture supernatants of vaginal lactobacilli on uropathogenic E.coli was determined by the diffusion technique on agar plate (Juárez Tomás et al. 2011) . Lactobacillus supernatants (from the third sub-culture), obtained by centrifugation (6000×g, 10 min) were divided into three fractions. One fraction was assayed without treatment (crude supernatant), the second was neutralized with NaOH (2 mol/l), and the third one was neutralized and treated with catalase (1000 U/ml). Crude and treated supernatants (25 µl) were seeded in agar plate holes (4 mm) containing the different E. coli strains at three concentrations (Table 2 ). Each one of the E. coli strains was plated in BHI-1% agar and LAPTg-1% agar. The plates were incubated for 5 h at room temperature and then for 24 h at 37 °C. The inhibition halos of the pathogen growth originated by the Lactobacillus supernatants were determined as millimeters.
HeLa cells assay
Bacterial culture conditions L. reuteri CRL 1324 was used to assess the in vitro inhibitory capability against E. coli 275 infection in eukaryotic HeLa cells. Bacteria from the third sub-culture in MRS were washed once with phosphate-buffered saline (PBS) and resuspended at different concentrations in Dulbecco's modified Eagle's medium (DMEM; pH 7.4; D. Dutscher, Brumath, France). Bacterial numbers were estimated by a VWR V-1200 spectrophotometer at 650 nm (VWR, France) and by the viable cell numbers using a micro method previously described (Baron et al. 2006) . The E. coli 275 population (in CFU/ml) was determined on MacConkey agar plates after 24 h of incubation at 37 °C. The L. reuteri CRL 1324 viable cells number was counted on MRS agar plates (pH 5.4) incubated for 48 h at 37 °C.
HeLa cells and culture conditions
HeLa cells were cultured in T75 cell culture flasks using DMEM medium containing 10% heat-inactivated fetal calf serum (FCS). Cells were incubated at 37 °C in a humidified incubator with 5% CO 2 . The HeLa cells were cultured to obtain a confluent monolayer, treated with 0.05% trypsin (Gibco-BRL, Grand Island, NY) and resuspended in fresh medium at a concentration of 2 × 10 5 cells/ml. Cells were counted in a Malassez chamber. For adhesion and internalization assays, cells were then seeded in 12-well plates (2 × 10 5 cells/well) and incubated overnight at 37 °C in 5% CO 2 to obtain a confluent monolayer.
Adhesion assays
The adhesion assays were adapted from Almeida et al. (1996) and Bouchard et al. (2013) , and modified as follows. Confluent monolayers of HeLa cells (2.5 × 10 5 cells/well) were washed four times with PBS and incubated at 37 °C in 5% CO 2 with 1 ml of E. coli 275 suspension in DMEM at 2.5 × 10 7 CFU/ml to achieve a 100:1 multiplicity of infection (MOI; ratio of E. coli cells to HeLa cells). Adhesion assays with L. reuteri CRL 1324 were performed by adding 1 ml of L. reuteri at 1.0 × 10 8 CFU/ml or 5.0 × 10 8 CFU/ml For the inhibition of adhesion assays, HeLa cells were incubated with L. reuteri CRL 1324 at a ROI of 400:1 or 2000:1 and E. coli 275 (MOI 100:1) for 1 h at 37 °C with 5% CO 2 . After the incubation steps, HeLa monolayers were washed four times with PBS and treated with 0.05% trypsin for 10 min at 37 °C. HeLa cells were centrifuged for 5 min at 800×g and lysed using 100 µl of 0.01%Triton in sterile water. The population of bacteria adhered (CFU/ml) was determined using the micromethod as described before.
The adhesion assay of E. coli was used as a reference. Adhesion rates were defined as the adhered E. coli population in the presence of L. reuteri referred to the adhered E. coli population in the experimental procedure.
Internalization assays
Internalization assays were adapted from Almeida et al. (1996) and Bouchard et al. (2013) E. coli and L. reuteri CRL 1324 internalization was quantified at 2 h post-infection following an additional 2 h incubation step with DMEM supplemented with gentamicin (100 µg/ml). This step produced the killing of extracellular bacteria and allowed only the quantification of the internalized bacterial population. Subsequently, HeLa monolayers were washed four times with PBS, treated with trypsin, centrifuged for 5 min at 800×g, and lysed in 0.01% Triton. E. coli and L. reuteri populations were determined as described above.
The internalization assay of E. coli was used as a reference. Internalization rates were then defined as the internalized E. coli population in the presence of L. reuteri CRL 1324 referred to the internalized E. coli population in the experimental protocol.
Statistical analysis
Each experiment was done in triplicate (biological repeats). Statistical analysis was performed using R software (R development Core Team 2013). The differences in adhesion and internalization capacities of E. coli in the presence of L. reuteri were assessed using one-way analysis of variance, considering as statistically significant a p value lower than 0.05.
Results and discussion
Susceptibility of E. coli to antagonistic substances by lactobacilli
The crude supernatants from L. reuteri CRL 1324 and L. rhamnosus CRL 1332 cultures inhibited the growth of UPEC strains, as shown in Table 2 . L. reuteri CRL 1324 supernatants produced higher zones of inhibition when the pathogen was grown in LAPTg (halo size = 5.5-10 mm) instead of BHI (halo size = 0-5 mm). In general, the inhibition produced by L. reuteri CRL 1324 on the pathogens grown in LAPTg was higher when the inoculum of the pathogen in agar plates was lower. Similar inhibition patterns were obtained when L. reuteri CRL 1324 was grown in MRS and MRS-T. The L. rhamnosus CRL 1332 supernatants from MRS inhibited E. coli growth and the inhibition was higher when the pathogen was cultured in LAPTg. In the present work, the neutralized and catalase-treated supernatants did not show the inhibition of the pathogen, indicating that the inhibitory effect is by the production of organic acids (data not shown). L. gasseri CRL 1263 did not inhibit any of the two E. coli strains assayed.
The results reported in this work are in partial agreement with those published by several authors reporting that the inhibition of UPEC by lactic acid bacteria (LAB) isolated from human vagina is related to lactic acid production. However, production of hydrogen peroxide by these LAB strains was frequently published. Cadieux et al. (2009) have evidenced that the culture supernatants of L. rhamnosus GR-1 and L. reuteri RC-14 (isolated from human vagina and distal urethra and vagina, respectively) inhibited the growth of UPEC C1212 by lactic acid and hydrogen peroxide production. Also the expression of type 1 fimbriae and P (adhesion factors) was affected. Atassi and Servin (2010) showed that L. gasseri KS120, isolated from human vagina, produced lactic acid and hydrogen peroxide, acting cooperatively to inhibit enteric (Salmonella enterica serotype Typhimurium SL1344), vaginal (Gardnerella vaginalis DSM 4944) and urinary tract pathogens (E. coli CFT073). The potential inhibition of pathogens by LAB isolated from the urogenital tract has sometimes been associated to bacteriocin production. For example, Razzaket al. (2011) have published that four isolates of lactobacilli (from vaginal swabs) showed potent bacteriocin activity against E. coli and Staphylococcus aureus indicator isolates, while previous results have shown the inhibitory effect of salivaricin CRL 13218 (Ocaña et al. 1999a, b; Vera Pingitore et al. 2012 ) on pathogens.
In healthy human vagina, a low pH limits the growth of different urogenital pathogens. E. coli colonization is not frequently isolated at low pH, but the risk of infections increases when vaginal pH is close to neutrality (Falagas et al. 2006) . O'Hanlon et al. (2013) suggested that when lactobacilli dominate the vaginal microbiota, women have more lactic acid mediating the protection against pathogens.
Adhesion and internalization of L. reuteri CRL 1324
Lactobacillus reuteri CRL 1324 was the strain that evidenced the highest E. coli inhibition. Therefore, this Lactobacillus strain was selected to assay its adhesion and internalization abilities into HeLa cells. L. reuteri (a heterofermentative bacterium) is considered as one of the Lactobacillus species autochthonous to humans and animals hosts (Hou et al. 2015) .
The results demonstrated that the adhesion abilities were significantly higher at a ROI of 2000:1 (7.33 × 10 5 CFU/ well) than at a ROI of 400:1 (1.53 × 10 5 CFU/well) (Fig. 1) . L. reuteri CRL 1324 exhibited poor internalization capabilities into the HeLa cells at the two ROI assayed (6 × 10 2 CFU/well at a ROI of 2000:1, and 1.28 × 10 2 CFU/ well at an ROI of 400:1), which corresponds to less than 1 internalized bacteria per 400 HeLa cells (data not shown).
Adhesion of lactobacilli to HeLa cells has been widely reported. For example, Joo et al. (2012) reported the adhesion of Lactobacillus helveticus HY7801 (a human vaginal isolate) to HeLa cells. Martín et al. (2012) showed that five human Lactobacillus strains strongly adhered to HeLa cells and suggested that aggregation-promoting factor-like proteins participate in the phenomenon. Verdenelli et al. (2014) evidenced that L. rhamnosus IMC 501, Lactobacillus paracasei IMC 502 and their SYNBIO (intestinal isolates) combination can adhere to HeLa cells, while these strains were able also to exert antimicrobial activity against pathogenic Candida strains. Parolin et al. (2015) demonstrated that the adhesive properties were different in several strains, with Lactobacillus crispatus BC1, L. crispatus BC3 and L. gasseri BC8 being the most adherent strains in their assay. The adherence of beneficial bacteria to eukaryotic cells is strain-and specie-specific usually being the mucus-binding proteins associated (Walsham et al. 2016; Hou et al. 2015) . Walsham et al. (2016) showed that CmbA and MUB increase the binding of L. reuteri to both HT-29 and LS174T cells. In a previous work, the presence of genes encoding for a mucus adhesion-promoting protein (MapA), a mucus-binding protein (MubI) and a cell and mucus-binding protein (CmbA) was evidenced in L. reuteri CRL 1324 (Leccese Terraf et al. 2014) , and further studies will be carried out to evaluate the involvement of these proteins in the adhesion process.
Effect of L. reuteri CRL 1324 on the adhesion and internalization of E. coli to HeLa cells
The adhesion of lactobacilli to the vaginal mucosa is significant to promote and help in the probiotic action (Martín et al. 2013) . The effects of lactobacilli on different urogenital pathogens were demonstrated on HeLa cells, including Gardnerella vaginalis, Candida albicans by different authors (Joo et al. 2011 (Joo et al. , 2012 Parolin et al. 2015; Santos et al. 2016 ) and E. coli (Atassi et al. 2006) .
In this study, L. reuteri CRL 1324 and E. coli 275 were co-incubated with HeLa cells to determine if the Lactobacillus strains can affect the pathogen adhesion. L. reuteri at a ROI of 2000:1 reduced the adhesion rate of E. coli at a MOI of 100:1, decreasing by 30% the adhesion observed with E. coli 275 (Fig. 2) . However, L. reuteri CRL 1324 at a ROI of 400:1 did not significantly affect the adhesion rate of E. coli.
UPEC can invade host uroepithelial tissue and once internalized can persist in quiescence for long periods without causing clinical symptoms (Mulvey et al. 2001) . The co-incubation of L. reuteri CRL 1324 and E. coli 275 with HeLa cells partially inhibited the pathogen internalization as shown in Fig. 3 . L. reuteri CRL 1324 with a ROI of 400:1 and 2000:1 led to a significant decrease of E. coli internalization rates by 51-57%. In the present work, the mechanism of competition between L. reuteri CRL 1324 and E. coli 275 for HeLa cell adhesion was assayed (coincubation of lactobacilli, HeLa cells and pathogen) and demonstrated. However, other researchers evaluated the mechanism of exclusion, through the incubation of lactobacilli and epithelial cells or mucus followed by pathogen 5 HeLa cells) + standard error. Each experiment was performed in triplicate, and differences between groups were compared using Student's t test 1 3 addition (Li et al. 2008; Walsham et al. 2016) . Walsham et al. (2016) Few studies have investigated the ability of LAB to modulate the internalization of pathogens on host cells. The results presented in this work are similar to those reported by Atassi et al. (2006) , who demonstrated the inhibition of adhesion to and internalization into HeLa cells of E. coli IH11128 by adhering vaginal Lactobacillus strains. Delley et al. (2015) showed that L. johnsonii NCC533, L. johnsonii NCC2917 and L. rhamnosus NCC4007 (commercial probiotics) reduced the adhesion of two UPEC strains (E. coli UTI89 and E. coli CFT073) to human bladder cancer cell line UM-UC-3; however, the results were not significant.
Conclusions
The results obtained in this work indicate that L. reuteri CRL 1324 and L. rhamnosus CRL 1332 were able to in vitro inhibit the growth of UPEC strains by organic acids production. Also L. reuteri CRL 1324 inhibited E. coli 275 adherence to and internalization into HeLa cells. In this way, this strain can be proposed as a beneficial Lactobacillus, which could generate some type of protection against urogenital infections. In vivo trials are being performed to advance in the design of probiotics formulations for the prevention and/or treatment of urinary tract infections. An adhesion assay of E. coli 275 alone was used as a reference. The adhered E. coli population in the reference experiment (corresponding to 100% adhesion rate) corresponds to 2.3 × 10 6 CFU/well and 2.72 × 10 6 CFU/well for the assay with L. reuteri at ROI 400:1 and 2000:1, respectively. Adhesion rates were then defined as the adhered E. coli 275 population in the presence of L. reuteri relative to the adhered E. coli 275 population in the reference experiment. Data are presented as means + standard error. Each experiment was done in triplicate, and differences between groups were compared using Student's t test reuteri CRL 1324 at a ROI of 400:1 and 2000:1. E. coli 275 was used at a MOI of 100:1. An internalization assay of E. coli 275 alone was used as a reference. The adhered E. coli population in the reference experiment (corresponding to 100% adhesion rate) corresponds to 2.24 × 10 2 CFU/well and 4.60 × 10 2 CFU/well for the assay with L. reuteri at ROI 400:1 and 2000:1, respectively. Internalization rates were then defined as the internalized E. coli 275 population in the presence of L. reuteri relative to the internalized E. coli 275 population in the reference experiment. Data are presented as means + standard error. Each experiment was done in triplicate, and differences between groups were compared using Student's t test
